Ever wondered how scientists are staying one step ahead of viruses and diseases? It's not just about lab coats and test tubes anymore; artificial intelligence is stepping into the game, changing the way we understand the very chemistry of life. Let's dive in!
USC's Nobel laureate, Arieh Warshel, has been at the forefront of this revolution. For years, he used computer simulations to understand enzymes, the workhorses of our cells. But as the complexity of biological systems grew, his simulations hit a wall. They couldn't accurately predict how mutations in enzymes affected their function, especially in viruses.
Warshel's approach? Adapt and overcome. He pivoted to artificial intelligence, seeking a new way to solve the puzzle. "I never leave a problem," he says. "I just attack it from different directions."
His initial AI-driven work focused on predicting how mutations alter enzyme activity, particularly in viruses like HIV and HCV. These viruses evolve rapidly, developing mutations that allow them to evade drug treatments.
Warshel's team made a fascinating discovery: the speed of an enzyme's activity strongly correlated with a statistical measure called "maximum entropy." This breakthrough meant they could use a purely computational approach to predict enzyme function.
This opened a new avenue: Could maximum entropy predict how viruses outsmart drugs? Warshel had tackled this before, creating models to forecast HIV mutations, but the virus was always one step ahead. The question remained: was there a better way?
But here's where it gets controversial...
Warshel's life is a testament to determination. Born in 1940, he grew up on an Israeli kibbutz, where his parents instilled a spirit of innovation. He experimented with parachutes for cats and built model airplanes powered by flies. In the army, he mastered Morse code, always with an eye on higher education. He eventually chose chemistry at Technion, the Israel Institute of Technology, and the rest, as they say, is history.
Applying maximum entropy to the drug resistance problem, Warshel started with HIV. The results were interesting but ultimately disappointing. Maximum entropy did correlate with patterns of drug resistance, but so did a simpler measure: the raw number of mutations. HIV mutates in almost any way imaginable, making it incredibly difficult to predict its next move.
So, the team shifted their focus to pathogens with more constrained evolutionary landscapes, like the hepatitis C virus (HCV). Here, the results were different. Maximum entropy aligned with the mutations the virus adopted under drug pressure, potentially forecasting its next move.
The team's findings, published in the Proceedings of the National Academy of Sciences, suggest that maximum entropy could be a powerful tool in the fight against drug resistance.
And this is the part most people miss...
Beyond viruses, maximum entropy showed remarkable results in other biological problems, including diseases linked to myosin, a molecular motor essential for muscle contraction, heart function, and hearing. The method was easier, faster, and often more accurate than previous methods.
Warshel's team is now using maximum entropy to predict how effectively myosin "walks," illuminating complex biological behavior with unexpected precision.
While HIV remains a challenge, the broader lesson is that maximum entropy has become a powerful lens for understanding how biological systems respond to mutation, potentially reshaping research across fields.
"We keep pushing on drug resistance," Warshel says. "But we’re having much more success in enzyme design and in predicting diseases like heart conditions and hearing loss. Maximum entropy works beautifully for these problems."
What do you think? Do you believe AI will revolutionize how we combat diseases? Share your thoughts in the comments below!
